Lapatinib Completed Phase 1 Trials for Malignancies Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT01290354Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer